Giura Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Giura Pharma
Largest movements
- Financial fixed assets +€300,000
up €300,000 (+63.2%), from €475,000 to €775,000
- Receivables within one year +€66,861
up €66,861 (+102%), from €65,832 to €132,693
of which Trade receivables: +€61,500
- Cash -€50,587
down €50,587 (-36.7%), from €137,992 to €87,405
mainly Investment in fixed assets (net) (-€300,000) and Receivables within one year (-€66,861)
- Current portion of long-term debt +€118,777
up €118,777 (+552%), from €21,520 to €140,297
- Debts after one year +€114,703
up €114,703 (+42.8%), from €267,713 to €382,416
- Reserves +€81,021
up €81,021 (+29.4%), from €275,515 to €356,536
- Gross operating margin +€12,817
up €12,817 (+11.7%), from €109,673 to €122,490
- Taxes +€4,280
up €4,280 (+12.3%), from €34,938 to €39,218
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €680,346 | €996,842 | +€316,496 | +46.5% |
| Fixed assets | 21/28 | €475,000 | €775,000 | +€300,000 | +63.2% |
| Financial fixed assets | 28 | €475,000 | €775,000 | +€300,000 | +63.2% |
| Current assets | 29/58 | €205,346 | €221,842 | +€16,496 | +8.0% |
| Amounts receivable within one year | 40/41 | €65,832 | €132,693 | +€66,861 | +102% |
| Trade receivables | 40 | €40,000 | €101,500 | +€61,500 | +154% |
| Other amounts receivable | 41 | €25,832 | €31,193 | +€5,361 | +20.8% |
| Cash at bank and in hand | 54/58 | €137,992 | €87,405 | -€50,587 | -36.7% |
| Deferred charges and accrued income | 490/1 | €1,522 | €1,744 | +€222 | +14.6% |
| Total equity and liabilities | 10/49 | €680,346 | €996,842 | +€316,496 | +46.5% |
| Equity | 10/15 | €380,436 | €461,457 | +€81,021 | +21.3% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €275,515 | €356,536 | +€81,021 | +29.4% |
| Distributable reserves | 133 | €275,515 | €356,536 | +€81,021 | +29.4% |
| Profit (loss) carried forward | 14 | €86,321 | €86,321 | = | 0.0% |
| Amounts payable | 17/49 | €299,910 | €535,385 | +€235,475 | +78.5% |
| Amounts payable after more than one year | 17 | €267,713 | €382,416 | +€114,703 | +42.8% |
| Financial debts | 170/4 | €267,713 | €382,416 | +€114,703 | +42.8% |
| Amounts payable within one year | 42/48 | €30,029 | €150,901 | +€120,872 | +403% |
| Current portion of amounts payable after more than one year | 42 | €21,520 | €140,297 | +€118,777 | +552% |
| Trade debts | 44 | €976 | €993 | +€17 | +1.7% |
| Suppliers | 440/4 | €976 | €993 | +€17 | +1.7% |
| Taxes, remuneration and social security | 45 | €6,664 | €9,611 | +€2,947 | +44.2% |
| Taxes | 450/3 | €6,664 | €9,611 | +€2,947 | +44.2% |
| Other amounts payable | 47/48 | €869 | - | -€869 | |
| Accrued charges and deferred income | 492/3 | €2,168 | €2,068 | -€100 | -4.6% |
| Other operating charges | 640/8 | €505 | €520 | +€14 | +2.8% |
| Gross operating margin | 9900 | €109,673 | €122,490 | +€12,817 | +11.7% |
| Operating profit (loss) | 9901 | €109,168 | €121,971 | +€12,803 | +11.7% |
| Financial income | 75/76B | €2,158 | €2,363 | +€205 | +9.5% |
| Recurring financial income | 75 | €2,158 | €2,363 | +€205 | +9.5% |
| Financial charges | 65/66B | €4,253 | €4,094 | -€159 | -3.7% |
| Recurring financial charges | 65 | €4,253 | €4,094 | -€159 | -3.7% |
| Profit (loss) for the period before taxes | 9903 | €107,072 | €120,239 | +€13,167 | +12.3% |
| Income taxes | 67/77 | €34,938 | €39,218 | +€4,280 | +12.3% |
| Profit (loss) for the period | 9904 | €72,134 | €81,021 | +€8,887 | +12.3% |
| Profit (loss) for the period to be appropriated | 9905 | €72,134 | €81,021 | +€8,887 | +12.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.